Not applicableStudy completedNCT02710487What this trial is testingSleep, Awake & Move - Part IIWho this might be right forIdiopathic Parkinson's Disease Neurocenter of Southern Switzerland 24
Early research (Phase 1)Study completedNCT00006488What this trial is testingContinuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease National Center for Research Resources (NCRR)
Not applicableStudy completedNCT00599339What this trial is testingTransdermal Rotigotine User Surveillance StudyWho this might be right forIdiopathic Parkinson Disease UCB Pharma 2,195
Testing effectiveness (Phase 2)Ended earlyNCT01856439What this trial is testingLong Term Safety and Efficacy Study of ProSavin in Parkinson's DiseaseWho this might be right forParkinson's Disease Axovant Sciences Ltd. 15
Not applicableStudy completedNCT04524143What this trial is testingThe Acute Effect of Cervical Mobilization in Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's Disease Hacettepe University 33
Not applicableStudy completedNCT03156647What this trial is testingAlpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian SyndromeWho this might be right forParkinson DiseaseParkinsonian Disorders Centre Hospitalier Universitaire de Nīmes 80
Large-scale testing (Phase 3)Study completedNCT00242008What this trial is testingA Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's DiseaseWho this might be right forParkinson's Disease UCB Pharma
Post-approval studies (Phase 4)UnknownNCT06115538What this trial is testingComparison of Dopamin Level in Idiopathic Parkinson's PatientsWho this might be right forParkinson DiseaseTreatment Adherence Ankara Ataturk Sanatorium Training and Research Hospital 96
Testing effectiveness (Phase 2)Study completedNCT01211587What this trial is testingA Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's DiseaseWho this might be right forParkinson's Disease With Cognitive Impairments Newron Pharmaceuticals SPA 103
Not applicableStudy completedNCT02723396What this trial is testingSleep, Awake & Move - Part IWho this might be right forIdiopathic Parkinson Disease Neurocenter of Southern Switzerland 67
Not applicableUnknownNCT06439355What this trial is testingSingle-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential AnalysisWho this might be right forIdiopathic Parkinson's Disease and Lewy Body Disease Centre Hospitalier Universitaire Dijon 66
Large-scale testing (Phase 3)Study completedNCT03670953What this trial is testingEvaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor FluctuationsWho this might be right forParkinson's Disease (Disorder) Impax Laboratories, LLC 630
Testing effectiveness (Phase 2)Study completedNCT00279825What this trial is testingComparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's Disease Impax Laboratories, LLC 16
Post-approval studies (Phase 4)Study completedNCT01744496What this trial is testingStudy to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainWho this might be right forAdvanced Idiopathic Parkinson's Disease UCB BIOSCIENCES GmbH 68
Not applicableStudy completedNCT02231255What this trial is testingPost Marketing Surveillance Study in Patients With Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease Boehringer Ingelheim 1,216
Large-scale testing (Phase 3)Study completedNCT00642889What this trial is testingSafinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)Who this might be right forParkinson's Disease Newron Pharmaceuticals SPA 227
Early research (Phase 1)Study completedNCT00252850What this trial is testingSafety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's DiseaseWho this might be right forParkinson's Disease Sangamo Therapeutics 12
Testing effectiveness (Phase 2)WithdrawnNCT05103618What this trial is testingEffect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPAWho this might be right forParkinson DiseaseIdiopathic Parkinson Disease Andrew Newberg
Not applicableStudy completedNCT01330290What this trial is testingCaregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver SupportWho this might be right forIdiopathic Parkinson's Disease UCB Pharma 148
Not applicableStudy completedNCT03037463What this trial is testingMeasuring Parkinson's Disease With Tear FluidWho this might be right forIdiopathic Parkinson Disease University of Southern California 205